Sağ Koroner Arter Girişimi Sonrası Gelişen Kateter Kaynaklı Sol Ana Koroner Arter Trombozunun Stent İmplantasyonu Gerektirmeyen Başarılı Yönetimi

Yazarlar

Bahar Güzel

Özet

Girişimsel kardiyolojide teknolojik gelişmeler işlem başarısını artırmış ve majör komplikasyon oranlarını azaltmış olsa da, sol ana koroner arteri etkileyen iyatrojenik olaylar halen yüksek mortalite ve morbidite riski taşımaktadır. Bu olguda, sağ koroner artere başarılı perkütan koroner girişim uygulanan 74 yaşındaki erkek hastada işlemden yaklaşık sekiz saat sonra gelişen kardiyak arrest sonrasında saptanan kateter ilişkili subtotal sol ana koroner arter trombozu sunulmaktadır. Acil koroner anjiyografi sonrasında düşük basınçlı balon dilatasyonu, mekanik trombüs parçalanması ve intrakoroner tirofiban tedavisi uygulanmış; stent implantasyonuna ihtiyaç duyulmaksızın tam koroner akım sağlanmıştır. Bu olgu, işlem sonrası gelişen ani ve açıklanamayan hemodinamik bozulmalarda kateter kaynaklı tromboz olasılığının ayırıcı tanıda düşünülmesi gerektiğini ve yapısal damar hasarı bulunmayan seçilmiş hastalarda stentsiz perkütan yaklaşımın başarılı olabileceğini göstermektedir.

Although technological advances in interventional cardiology have improved procedural success and reduced the rate of major complications, iatrogenic events involving the left main coronary artery continue to be associated with high mortality and morbidity. In this case, we present a 74-year-old man who developed catheter-related subtotal left main coronary artery thrombosis following cardiac arrest approximately eight hours after successful percutaneous coronary intervention of the right coronary artery. Emergency coronary angiography was performed, followed by low-pressure balloon dilatation, mechanical thrombus disruption, and intracoronary tirofiban administration, resulting in complete restoration of coronary blood flow without the need for stent implantation. This case demonstrates that catheter-related thrombosis should be considered in the differential diagnosis of sudden and unexplained hemodynamic deterioration after percutaneous coronary intervention and that a stent-free percutaneous approach may be successful in selected patients without structural vessel injury.

Referanslar

Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. J Am Coll Cardiol. 2022;79(2):e21-e129.

Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165.

Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119-177.

Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and prevention of sudden cardiac death. J Am Coll Cardiol. 2018;72(14):e91-e220.

Ramasamy A, Bajaj R, Jones DA, et al. Iatrogenic catheter-induced ostial coronary artery dissections: Prevalence, management, and mortality from a cohort of 55,968 patients over 10 years. Catheter Cardiovasc Interv. 2020;96(6):E560-E567.

Cereda AF, Penso M, Tundo F, et al. Iatrogenic aorta-coronary dissection: case report and systematic review. Catheter Cardiovasc Interv. 2021;97(5):E900-E909.

Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-3826.

Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction. Circulation. 2016;133(11):1135-1147.

Bhatt DL, Lopes RD, Harrington RA. Diagnosis and Treatment of Acute Coronary Syndromes: A Review. JAMA. 2022;327(7):662-675.

Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289-1367.

Tian R, Chen Y, Zhang J, et al. Efficacy and safety of intracoronary versus intravenous tirofiban in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Sci Rep. 2023;13(1):14312.

Yayınlanan

5 Ağustos 2026

Lisans

Lisans